Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15611490 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Bortezomib in Late Antibody-mediated Kidney Transplant Rejection
Conditions: Late Rejection of Renal Transplant;   Antibody-mediated Rejection
Interventions: Drug: Bortezomib;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.